Peresolimab met the primary efficacy endpoint in patients with refractory rheumatoid arthritis (RA) Study evaluated a novel approach to treating patients with autoimmune diseases INDIANAPOLIS, May 18, 2023 /PRNewswire/ — The New England Journal of Medicine today published detailed…
